Top Markets
Coin of the day
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc.

AURX
Rangering i aksjer #25548
Nuo Therapeutics, Inc. operates as a regenerative medicine company,... Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds. Established in Houston, Texas, in 1998, the company underwent a name change from Cytomedix, Inc. to Nuo Therapeutics, Inc. in November 2014.
Aksjekurs
$1.00
Sist synkronisert: 2026-08-19
Markedsverdi
$48.41M
Endring (1 dag)
0.00%
Endring (1 år)
-41.86%
Land
US
Handel Nuo Therapeutics, Inc. (AURX)

Kategori

Pris AURX pris med markedsverdi på B
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
AURX
$1.00
Markedsverdi av Nuo Therapeutics, Inc.(AURX)
Markedsverdi: $48.41M
Per August 2026 har Nuo Therapeutics, Inc. en markedsverdi på $48.41M. Dette gjør Nuo Therapeutics, Inc. til det 25548th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Nuo Therapeutics, Inc. fra 2017 til 2026
AURX sammenlignet med topp 5 mest populære stocks
Pris på AURX Eiendel B Markedsverdi for B Resultater
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$108,592 $48.41M
$5.257T +10,859,108.56%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$94,995.50 $48.41M
$4.599T +9,499,449.68%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$84,830.71 $48.41M
$4.107T +8,482,970.80%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$73,896.21 $48.41M
$3.577T +7,389,521.11%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$57,991.20 $48.41M
$2.807T +5,799,020.33%